NSE filing, NSE: JFLLIFE. Summary written from the filing by ALFA Finder's alert engine.
JFL Life Sciences Ltd: key numbers
- Share price
- ₹9.80
- Market cap
- ₹64.67 Cr
- Revenue (annual)
- ₹131.4 Cr
- Net profit (annual)
- ₹6.40 Cr
- P/E (TTM)
- 10.1×Sector 46.1×
- Promoter holding
- 67.47%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JFL Life Sciences Ltd
All →JFL Life Sciences Other Announcement
JFL Life Sciences Limited submitted the Regulation 74(5) compliance certificate from its Registrar, KFin Technologies Limited, for the quarter ended September 30, 2026.
JFL Life Sciences Management Change
JFL Life Sciences Limited announced the re-appointment of its Managing Director, Whole-time Director, and two Independent Directors, each for a five-year term.
JFL Life Sciences Annual General Meeting
Jfl Life Sciences Limited held its 16th Annual General Meeting on August 25, 2026, via video conferencing to transact business as per the notice.
JFL Life Sciences Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 57.1% YoY
JFL Life Sciences Ltd reported revenue from operations of ₹11.1 Cr (-4.3% YoY) and net profit of ₹1.1 Cr (+57.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +57.1% YoY
JFL Life Sciences Board Meeting Date
JFL Life Sciences Limited will hold a board meeting on 10-Aug-2026 to approve the company's unaudited standalone financial results for the quarter ended June 2026.
JFL Life Sciences Annual General Meeting
JFL Life Sciences Limited issued a notice for its 16th Annual General Meeting, scheduled for August 25, 2026, to consider financial and managerial appointments.
Other other announcement announcements
All →KRN Heat Exchanger and Refrigeration Other Announcement
KRN Heat Exchanger filed its Reg 32 statement confirming no deviation in QIP fund use, with INR 349.99 Crore raised on 1 June 2026. The utilisation table reports no variation across the three objects.
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.